Literature DB >> 7093121

Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia.

F A Stewart, J Denekamp, V S Randhawa.   

Abstract

Skin reactions on irradiated mouse feet were used to measure the radiosensitization of normal tissues by misonidazole (MISO). Fractionation schedules of 1, 2, 5 and 10 daily doses of X-rays were combined with either 100 mg/kg or 670 mg/kg MISO. When unanaesthetized mice were irradiated in air, significant sensitization was observed with both the high and low drug doses, in all fractionation schedules. There was no decrease in sensitization with fractionation, even using fractions as small as 5 Gy. This indicates that many of the cells in mouse skin may be marginally hypoxic, and that sensitization at low doses is possible. Irradiation in O2 without MISO rendered the skin more sensitive to X-rays than in air. MISO given 30 min before single doses of radiation further sensitized the skin, but for 10 fractions in O2 no MISO sensitization was detected. There was little evidence for cytotoxic killing in skin by MISO. Repair of radiation damage was slightly reduced when MISO was present, during or after irradiation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7093121      PMCID: PMC2011034          DOI: 10.1038/bjc.1982.139

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  33 in total

1.  Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo.

Authors:  J Denekamp; B D Michael; S R Harris
Journal:  Radiat Res       Date:  1974-10       Impact factor: 2.841

2.  Hypoxic sensitizers: radiobiological studies at the cellular level.

Authors:  E J Hall; L Roizin-Towle
Journal:  Radiology       Date:  1975-11       Impact factor: 11.105

3.  Residual radiation damage in mouse skin 5 to 8 months after irradiation.

Authors:  J Denekamp
Journal:  Radiology       Date:  1975-04       Impact factor: 11.105

4.  The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.

Authors:  J Denekamp; S R Harris
Journal:  Radiat Res       Date:  1976-04       Impact factor: 2.841

5.  Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.

Authors:  J M Brown
Journal:  Radiat Res       Date:  1975-12       Impact factor: 2.841

6.  Skin reactions in mice after multifraction x-irradiation.

Authors:  J F Fowler; J Denekamp; C Delapeyre; S R Harris; P W Sheldon
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1974-03

7.  Selective chemotherapy of noncycling cells in an in vitro tumor model.

Authors:  R M Sutherland
Journal:  Cancer Res       Date:  1974-12       Impact factor: 12.701

8.  The effect of radiation on the growth of vertebrae in the tails of rats. I. Single doses of x-rays and the effect of oxygen.

Authors:  B Dixon
Journal:  Int J Radiat Biol Relat Stud Phys Chem Med       Date:  1967

9.  Radiation depigmentation of mouse hair: the influence of local tissue oxygen tension on radiosensitivity.

Authors:  C S Potten; A Howard
Journal:  Radiat Res       Date:  1969-04       Impact factor: 2.841

10.  Fractionation with x rays and neutrons in mice: response of skin and C 3 H mammary tumours.

Authors:  J F Fowler; J Denekamp; A L Page; A C Begg; S B Field; K Butler
Journal:  Br J Radiol       Date:  1972-04       Impact factor: 3.039

View more
  16 in total

Review 1.  Interplay between Candida albicans and the antimicrobial peptide armory.

Authors:  Marc Swidergall; Joachim F Ernst
Journal:  Eukaryot Cell       Date:  2014-06-20

2.  HIF1alpha delays premature senescence through the activation of MIF.

Authors:  Scott M Welford; Barbara Bedogni; Katarina Gradin; Lorenz Poellinger; Marianne Broome Powell; Amato J Giaccia
Journal:  Genes Dev       Date:  2006-12-01       Impact factor: 11.361

3.  Oxygen deprivation inhibits basal keratinocyte proliferation in a model of human skin and induces regio-specific changes in the distribution of epidermal adherens junction proteins, aquaporin-3, and glycogen.

Authors:  Joely A Straseski; Angela L Gibson; Christina L Thomas-Virnig; B Lynn Allen-Hoffmann
Journal:  Wound Repair Regen       Date:  2009 Jul-Aug       Impact factor: 3.617

Review 4.  Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin.

Authors:  Barbara Bedogni; Marianne Broome Powell
Journal:  Pigment Cell Melanoma Res       Date:  2009-02-13       Impact factor: 4.693

Review 5.  Understanding signaling cascades in melanoma.

Authors:  Pablo Lopez-Bergami; Boris Fitchman; Ze'ev Ronai
Journal:  Photochem Photobiol       Date:  2007-12-15       Impact factor: 3.421

6.  A reliable set of reference genes to normalize oxygen-dependent cytoglobin gene expression levels in melanoma.

Authors:  Joey De Backer; Darko Maric; Matthias Bosman; Sylvia Dewilde; David Hoogewijs
Journal:  Sci Rep       Date:  2021-05-25       Impact factor: 4.379

7.  Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.

Authors:  A Rojas; R J Hodgkiss; M R Stratford; M F Dennis; H Johns
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

8.  Clinical development of new drug-radiotherapy combinations.

Authors:  Ricky A Sharma; Ruth Plummer; Julie K Stock; Tessa A Greenhalgh; Ozlem Ataman; Stephen Kelly; Robert Clay; Richard A Adams; Richard D Baird; Lucinda Billingham; Sarah R Brown; Sean Buckland; Helen Bulbeck; Anthony J Chalmers; Glen Clack; Aaron N Cranston; Lars Damstrup; Roberta Ferraldeschi; Martin D Forster; Julian Golec; Russell M Hagan; Emma Hall; Axel-R Hanauske; Kevin J Harrington; Tom Haswell; Maria A Hawkins; Tim Illidge; Hazel Jones; Andrew S Kennedy; Fiona McDonald; Thorsten Melcher; James P B O'Connor; John R Pollard; Mark P Saunders; David Sebag-Montefiore; Melanie Smitt; John Staffurth; Ian J Stratford; Stephen R Wedge
Journal:  Nat Rev Clin Oncol       Date:  2016-06-01       Impact factor: 66.675

9.  Interaction of misonidazole and WR-2721--II. Modification of tumour radiosensitization.

Authors:  A Rojas; F A Stewart; J Denekamp
Journal:  Br J Cancer       Date:  1983-01       Impact factor: 7.640

10.  Expression and function of hypoxia inducible factor-1 alpha in human melanoma under non-hypoxic conditions.

Authors:  Caroline N Mills; Sandeep S Joshi; Richard M Niles
Journal:  Mol Cancer       Date:  2009-11-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.